Nu Skin Enterprises, Inc. Earnings Recaps
Q2 2026
Aug 13, 2026
Nu Skin’s shares dropped 11.3% following the quarter, reflecting investor disappointment primarily driven by cautious full-year guidance and ongoing challenges in sales force recruitment and leadership development, suggesting deceleration in core business momentum.
Key takeaways
- Q2 revenue reached approximately $320 million, supported by early growth in the Prysm iO device placements, which increased nearly 30% quarter-over-quarter to over 39,000 units.
- Adjusted EPS landed near the midpoint of the prior range, reflecting focus on profitability despite operational headwinds.
- Sales force recruitment and leadership development remain below levels necessary for sustained growth, limiting channel expansion despite global compensation framework adjustments.
- The company updated full-year revenue and EPS guidance downward, signaling caution about the near-term outlook.
- Continued investment in Prysm iO innovation and emerging markets aims to drive long-term growth but results have yet to translate into immediate top-line acceleration.
Q3 2025
Nov 8, 2025
Nu Skin Enterprises reported Q3 2025 revenue of $364 million, aligning with guidance, and delivered an EPS of $0.34, reflecting robust performance amid macro challenges. The company is poised for growth with the upcoming introduction of its Prysm iO wellness platform and entry into the Indian market.
Key takeaways
- Revenue declined year-over-year but remained within guidance; North America faced transformation challenges while Latin America grew 53%.
- Launch of Prysm iO, an intelligent wellness platform, scheduled for limited previews in Q4, aiming to enhance customer engagement and lifetime value.
- Expansion into India is a strategic focus, targeting a growing middle class with a tailored product portfolio and compensation plan to boost market presence.
- Sequential growth noted in Europe, Africa, South Korea, and Southeast Asia, signaling recovery in key international markets.
- Nu Skin's significant investment in intelligent wellness reflective of market trends, with a potential market for nutritional supplements anticipated to surpass $700 billion by 2030.